Impact of Continuous Erythropoietin Receptor Activator on Selected Biomarkers of Cardiovascular Disease and Left Ventricle Structure and Function in Chronic Kidney Disease

Background. Cardiovascular morbidity and mortality are very high in patients with chronic kidney disease (CKD). The purpose of this study is to evaluate the impact of continuous erythropoietin receptor activator (CERA) on selected biomarkers of cardiovascular disease, left ventricle structure, and f...

Descripción completa

Detalles Bibliográficos
Autores principales: Bartnicki, Piotr, Rysz, Jacek, Franczyk, Beata, Baj, Zbigniew, Majewska, Ewa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4789516/
https://www.ncbi.nlm.nih.gov/pubmed/27034745
http://dx.doi.org/10.1155/2016/9879615

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4789516/
https://www.ncbi.nlm.nih.gov/pubmed/27034745
http://dx.doi.org/10.1155/2016/9879615

Ejemplares similares